Chang-Ching Lin
3PUBLICATIONS
42CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Feb 24, 2025
ESR1 Y537S and D538G Mutations Drive Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer.Chang-Ching A Lin, María Rosario Chica-Parrado, Nisha Unni
|Mar 14, 2024
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.Chang-Ching Lin, Tsung-Cheng Chang, Yunguan Wang
|May 13, 2022
Epigenetic Repression of STING by MYC Promotes Immune Evasion and Resistance to Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer.Kyung-Min Lee, Chang-Ching Lin, Alberto Servetto
Pageof 1
Frequent Collaborators
3 joint publications
Ariella B Hanker
3 joint publications
Carlos L Arteaga
2 joint publications
Fabiana Napolitano
2 joint publications
Kyung-Min Lee
2 joint publications
Lin Xu
1 joint publications
María Rosario Chica-Parrado
1 joint publications
Nisha Unni
1 joint publications
Ellen Jaeger
1 joint publications
Yisheng V Fang
1 joint publications
Lei Guo
